Evaluation of the hypoglycemic effect of Cucurbita ficifolia Bouché (Cucurbitaceae) in different experimental models

2002 ◽  
Vol 82 (2-3) ◽  
pp. 185-189 ◽  
Author(s):  
F.J Alarcon-Aguilar ◽  
E Hernandez-Galicia ◽  
A.E Campos-Sepulveda ◽  
S Xolalpa-Molina ◽  
J.F Rivas-Vilchis ◽  
...  
1996 ◽  
Vol 148 (1) ◽  
pp. 139-148 ◽  
Author(s):  
A Amrani ◽  
M Jafarian-Tehrani ◽  
P Mormède ◽  
S Durant ◽  
J-M Pleau ◽  
...  

Abstract Cytokines, particularly interleukin 1 (IL-1) and tumor necrosis factor, are known to induce hypoglycemia in normal rodents or different experimental models of type II diabetes. We investigated, at the pre-diabetic stage, the effect of short-term administration of murine recombinant interleukin-1α (mrIL-1α) on the levels of glucose, insulin and corticosterone in the non-obese diabetic (NOD) mouse, a spontaneous model of type I diabetes. Two-month-old, pre-diabetic NOD mice of both sexes were insensitive to mrIL-1α (12·5 and 50 μg/kg) 2 h after administration, the time at which the maximal decrease (around 50%) was observed in the C57BL/6 mouse strain. Kinetic studies however showed that mrIL-1α lowered glycemia in both sexes of NOD mice, but the effect was limited and delayed. In the NOD and C57BL/6 strains, mrIL-1α had no influence on insulin levels in females, but significantly increased them in males (P<0·0001). Castration of NOD males abrogated the stimulatory effect of mrIL-1α on insulin secretion. Corticosterone secretion was stimulated by mrIL-1α in both sexes of NOD and C57BL/6 mice, and this effect was faster and greater in NOD females than in C57BL/6 females. The incomplete hypoglycemic response to mrIL-1α in females may be attributed to the anti-insulin effect of glucocorticoids, an effect which can be demonstrated when mrIL-1α is administered to adrenalectomized animals or when mrIL-1α is administered together with the glucocorticoid antagonist RU38486. In NOD males, in contrast, glucocorticoids did not play a major role in the limited hypoglycemic response to mrIL-1α, since RU38486 and adrenalectomy were not able to unmask a hypoglycemic effect. Moreover, NOD mice of both sexes were less sensitive than C57BL/6 mice to the hypoglycemic effect of insulin (2·5 U/kg), which suggests some degree of insulin-resistance in NOD mice. With regard to the effect of IL-1 on NOD mouse glycemia, therefore, these results suggest that glucocorticoids and/or androgens, according to the animal's sex, may induce a state of insulin-resistance. Journal of Endocrinology (1996) 148, 139–148


2020 ◽  
Vol 100 (14) ◽  
pp. 5171-5181
Author(s):  
Araceli Moya‐Hernández ◽  
Elsa Bosquez‐Molina ◽  
José Ramón Verde‐Calvo ◽  
Gerardo Blancas‐Flores ◽  
Gloria Maribel Trejo‐Aguilar

2018 ◽  
Vol 116 ◽  
pp. 110-115 ◽  
Author(s):  
A. Moya-Hernández ◽  
E. Bosquez-Molina ◽  
A. Serrato-Díaz ◽  
G. Blancas-Flores ◽  
F.J. Alarcón-Aguilar

1970 ◽  
Vol 19 (4) ◽  
pp. 2846-2853
Author(s):  
Amel Belgacem ◽  
Neyla Ben Gdara ◽  
Ikram Khemiri ◽  
Lotfi Bitri

Background and objectives: A lot of research has been directed towards medicinal plants which are considered as a source of multiple phytotherapic substances endowed with hypoglycemic activities that could be used to treat diabetes and its complications. Our study was carried out in Wistar rats to investigate the hypoglycemic effect of n-Butanol Fraction from Artemisia campestris leaf Methanolic Extract (BFACME).Methods: Two experimental models were used in rats: orally induced hyperglycemia (OGTT) and isolated perfused liver (IPRL).Results: BFACME at 550 mg/kg BW dose significantly reduced fasting glucose level in normal rats as compared to controls. The decrease of glycaemia was 12.6% more significant than that obtained with the standard drug glibenclamide (10 mg/kg BW), an oral antidiabetic preparation belonging to sulfonylurea class. In OGTT model, BFACME at the highest doses of 550 and 400 mg/kg BW significantly reduced the postprandial hyperglycemic peak compared to controls. In the IPRL model, treatment with BFACME significantly decreased glucose concentrations after 30 min of perfusion with 30 mM glucose solely when insulin was present. The higher doses of BFACME lead to glucose concentration at basal level as early as 90 min, while the lowest dose does not restore this concentration even to t = 120min. The best initial glucose concentration retrieval was obtained with 0.7 mg BFACME/mL/g liver. At this dose, BFACME improves the decrease of glucose level caused by only insulin by about 18%.Conclusion: The BFACME appears to exert a hypoglycemic activity by potentiating the insulin action. Keywords: Artemisia campestris; hypoglycemic activity; isolated perfused rat liver; rats.


2020 ◽  
Vol 134 (19) ◽  
pp. 2581-2595
Author(s):  
Qiuhong Li ◽  
Maria B. Grant ◽  
Elaine M. Richards ◽  
Mohan K. Raizada

Abstract The angiotensin-converting enzyme 2 (ACE2) has emerged as a critical regulator of the renin–angiotensin system (RAS), which plays important roles in cardiovascular homeostasis by regulating vascular tone, fluid and electrolyte balance. ACE2 functions as a carboxymonopeptidase hydrolyzing the cleavage of a single C-terminal residue from Angiotensin-II (Ang-II), the key peptide hormone of RAS, to form Angiotensin-(1-7) (Ang-(1-7)), which binds to the G-protein–coupled Mas receptor and activates signaling pathways that counteract the pathways activated by Ang-II. ACE2 is expressed in a variety of tissues and overwhelming evidence substantiates the beneficial effects of enhancing ACE2/Ang-(1-7)/Mas axis under many pathological conditions in these tissues in experimental models. This review will provide a succinct overview on current strategies to enhance ACE2 as therapeutic agent, and discuss limitations and future challenges. ACE2 also has other functions, such as acting as a co-factor for amino acid transport and being exploited by the severe acute respiratory syndrome coronaviruses (SARS-CoVs) as cellular entry receptor, the implications of these functions in development of ACE2-based therapeutics will also be discussed.


2001 ◽  
Vol 120 (5) ◽  
pp. A537-A537
Author(s):  
I GUKOVSKY ◽  
C REYES ◽  
E VAQUERO ◽  
A BAYCHER ◽  
A GUKOVSKAYA ◽  
...  
Keyword(s):  

1994 ◽  
Vol 27 (4) ◽  
pp. 663-675 ◽  
Author(s):  
Richard L. Goode ◽  
Shinsei Nishihara
Keyword(s):  

1986 ◽  
Vol 4 (1) ◽  
pp. 249-264 ◽  
Author(s):  
M.G. Täuber ◽  
R.A. Brooks-Fournier ◽  
M.A. Sande

Planta Medica ◽  
2014 ◽  
Vol 80 (16) ◽  
Author(s):  
RT Basting ◽  
HM Spindola ◽  
VH Silva Souza ◽  
R Grando ◽  
RA Ferreira Rodrigues ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document